Results 161 to 170 of about 2,366 (190)

Proteomic Dynamics of Multidrug Resistance Mechanisms in Lucena 1 Cell Line. [PDF]

Cells
Beraldo-Neto E, Amador FC, Fernandes KR, Justo GZ, Lacerda JT, Juliano MA.   +5 more
europepmc   +1 more source

CCM Function in the Heart: Working From Outside-In Rather Than Inside-Out. [PDF]

JACC Basic Transl Sci
Kahn ML.
europepmc   +1 more source

A renaissance of cerebral cavernous malformation proteins in vascular physiology. [PDF]

Nat Cardiovasc Res
Abdelilah-Seyfried S, Jo H.
europepmc   +1 more source

Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease. [PDF]

Genes Dis
Kar S, Perrelli A, Bali KK, Mastrocola R, Kar A, Khan B, Gand L, Nayak A, Hartmann C, Kunz WS, Samii A, Bertalanffy H, Retta SF.   +12 more
europepmc   +1 more source

TLNRD1 is a CCM complex component and regulates endothelial barrier integrity. [PDF]

J Cell Biol
Ball NJ, Ghimire S, Follain G, Pajari AO, Wurzinger D, Vaitkevičiūtė M, Cowell AR, Berki B, Ivaska J, Paatero I, Goult BT, Jacquemet G.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

KRIT1‐positive hyperkeratotic cutaneous capillary venous malformation

Pediatric Dermatology, 2021
AbstractCerebral cavernous malformations (CCM) may present in sporadic or familial forms, with different cutaneous manifestations including deep blue nodules, capillary malformations, and hyperkeratotic cutaneous capillary venous malformations (HCCVM). We report the case of an infant with a KRIT1‐positive HCCVM associated with familial CCM.
Bayan Matarneh, Catherine E. Cottrell, Samantha Choi, Gregory Pearson, Bonita Fung, Selene C. Koo, Anna P. Lillis, Mai‐Lan Ho, Esteban Fernandez Faith   +8 more
openaire   +2 more sources

KRIT1 ‐mediated regulation of neutrophil adhesion and motility

The FEBS Journal, 2022
Loss of Krev interaction‐trapped‐1 (KRIT1) expression leads to the development of cerebral cavernous malformations (CCM), a disease in which abnormal blood vessel formation compromises the structure and function of the blood–brain barrier. The role of KRIT1 in regulating endothelial function is well‐established.
Nicholas Nobiletti, Jing Liu, Angela J. Glading   +2 more
openaire   +2 more sources

Genetic Variations Within KRIT1/CCM1, MGC4607/CCM2 and PDCD10/CCM3 in a Large Italian Family Harbouring a Krit1/CCM1 Mutation

Journal of Molecular Neuroscience, 2010
Cerebral cavernous malformations (CCMs) are congenital vascular anomalies of the central nervous system that can result in seizures, haemorrhage, recurrent headaches and focal neurologic deficit. CCMs can occur as an autosomal dominant trait with incomplete penetrance and a wide phenotypic variability.
PILEGGI, S., BUSCANE, S., RICCI, C., PATROSSO, M. C., MAROCCHI, A., BRUNORI, P., BATTISTINI, S., PENCO, S.   +7 more
openaire   +8 more sources

Production of KRIT1-knockout and KRIT1-knockin Mouse Embryonic Fibroblasts as Cellular Models of CCM Disease

2020
The development of distinct cellular and animal models has allowed the identification and characterization of molecular mechanisms underlying the pathogenesis of cerebral cavernous malformation (CCM) disease. This is a major cerebrovascular disorder of proven genetic origin, affecting 0.5% of the population.
Goitre L., Fornelli C., Zotta A., Perrelli A., Retta S. F.   +4 more
openaire   +3 more sources